Neurogene Inc.
NGNE
$36.14
$0.511.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 1.26% | 22.57% | |||
| Gross Profit | -1.26% | -22.57% | |||
| SG&A Expenses | 36.63% | 19.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.96% | 21.67% | |||
| Operating Income | -9.96% | -21.67% | |||
| Income Before Tax | -11.49% | -25.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.49% | -25.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.49% | -25.06% | |||
| EBIT | -9.96% | -21.67% | |||
| EBITDA | -10.32% | -22.06% | |||
| EPS Basic | -10.28% | -23.81% | |||
| Normalized Basic EPS | -10.27% | -24.42% | |||
| EPS Diluted | -10.28% | -23.81% | |||
| Normalized Diluted EPS | -10.27% | -24.42% | |||
| Average Basic Shares Outstanding | 1.10% | 1.01% | |||
| Average Diluted Shares Outstanding | 1.10% | 1.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||